ANIK · ISSUER CIK 898437
Anika Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Anika Therapeutics, Inc. insiders reported $41K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Fischetti Gary P (Director), with $41K.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$41KInsider buying
$0.00Insider selling
+$41KNet open-market
Aug 5, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 202616:30 | Aug 4, 2026from Aug 3, 2026 | ANIK | Director | P · Buy | $20.53 | +2,000 | 54,015 | +4% | +$41K | +6.5% | +6.1% |